ALS and frontotemporal dementia: Early diagnosis thanks to an experimental test
Researchers are developing a test to diagnose two very serious diseases such as ALS and FTD when the pathologies have […]
» Read moreHome »
Scientists have developed a simple, experimental blood test that distinguishes pancreatic cancers that respond to treatment from those that do […] MONDAY, Feb. 10, 2020 — Two experimental drugs do not appear to slow memory loss or mental decline in patients […] An early stage trial of an investigational therapy for amyotrophic lateral sclerosis (ALS) suggests that people could tolerate the experimental […] Study of Novartis Access program in Kenya demonstrates it is possible to evaluate major pharmaceutical companies’ access programs using robust, […] An experimental drug is showing some promise in stopping mood abnormalities and cognitive disorders similar to those seen in people […] Congo has approved the use of four more experimental treatments in the Ebola virus outbreak in its northeast, as health […] The cell-signaling pathway is called RAS/MAPK and it influences many cell functions including growth, division, and death. Around half of […]
New experimental blood test determines which pancreatic cancers will respond to treatment
Two Experimental Drugs for Rare, Inherited Alzheimer Disease Disappoint
Experimental drug shows promise for genetic form of ALS
BU conducts first experimental evaluation of pharmaceutical industry-led access program
Experimental compound reduces Gulf War illness-like behavior in mice
Congo approves 4 experimental Ebola treatments in outbreak
Experimental drug may treat ‘undruggable’ cancers
